Antipsychotics are medications used to manage and treat symptoms of schizophrenia and other similar mental health disorders. They work by affecting the balance of certain chemicals in the brain, which can help reduce symptoms like hallucinations, delusions, and disorganized thinking. In this clinical trial, the focus is on comparing two strategies: reducing the dose of antipsychotics or maintaining the current dose, to see which approach is more effective for patients with different types of psychotic symptoms.

Schizophrenia – Schizophrenia is a chronic mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior. It often includes symptoms such as hallucinations, delusions, and disorganized thinking. The progression of schizophrenia can vary, with some individuals experiencing episodes of acute symptoms followed by periods of remission. Over time, cognitive and functional impairments may develop, affecting daily life and social interactions. The course of the disease can be influenced by various factors, including stress and substance use. Schizophrenia typically requires long-term management to help individuals maintain functionality.

Schizophreniform Disorder – Schizophreniform disorder is a mental health condition with symptoms similar to schizophrenia, such as hallucinations, delusions, and disorganized speech. However, the duration of these symptoms is shorter, typically lasting between one to six months. If symptoms persist beyond six months, the diagnosis may change to schizophrenia. The disorder can disrupt daily functioning and social relationships during its active phase. The progression can vary, with some individuals recovering fully, while others may develop more chronic conditions. Early intervention can play a role in the outcome of the disorder.

Schizoaffective Disorder – Schizoaffective disorder is a mental health condition that features symptoms of both schizophrenia and mood disorders, such as depression or bipolar disorder. Individuals may experience hallucinations or delusions alongside mood swings or depressive episodes. The disorder can lead to significant challenges in managing emotions and maintaining relationships. Symptoms can fluctuate, with periods of severe symptoms followed by times of improvement. The progression of schizoaffective disorder can vary widely among individuals. Long-term management is often necessary to address both psychotic and mood symptoms.

Brief Psychotic Disorder – Brief psychotic disorder is characterized by the sudden onset of psychotic symptoms, such as hallucinations, delusions, or disorganized speech, lasting for at least one day but less than one month. The symptoms can be severe and may cause significant distress or impairment in social or occupational functioning. The disorder often follows a stressful event or trauma, but the exact cause is not always clear. Recovery is typically rapid, with a full return to previous levels of functioning once symptoms resolve. The disorder is considered acute and self-limiting, with a low likelihood of recurrence. Early intervention can help manage symptoms and support recovery.